Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02736656
PHASE3

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Sponsor: Supernus Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Official title: Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of SPN-812 for the Treatment of Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)

Key Details

Gender

All

Age Range

4 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

1400

Start Date

2016-02-02

Completion Date

2026-09

Last Updated

2025-06-25

Healthy Volunteers

No

Interventions

DRUG

SPN-812

Cohort 'A': Children 6-11 yrs of age take 100-400mg SPN-812 once daily by mouth and adolescents 12-17 yrs of age take 100-600mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'A' are given a choice to extend their participation in the study every 6 months for up to 72 months. Cohort 'B': Pre-school-age children 4-5 yrs of age take 100mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'B' will be treated with 100 mg SPN-812 (100 mg capsule) for up to 6 months.

Locations (16)

Woodland International Research Group

Little Rock, Arkansas, United States

Alliance for Wellness dba Alliance for Research

Long Beach, California, United States

MCB Clinical Research Centers, LLC

Colorado Springs, Colorado, United States

Meridien Research at Florida Clinical Research Center

Bradenton, Florida, United States

Sarkis Clinical Trials

Gainesville, Florida, United States

Indago Research & Health Center, Inc.

Hialeah, Florida, United States

Florida Clinical Research Center, LLC.

Maitland, Florida, United States

Florida Clinical Research Center, LLC

Maitland, Florida, United States

IPS Research

Oklahoma City, Oklahoma, United States

Paradigm Research Professionals

Oklahoma City, Oklahoma, United States

Clinical Neuroscience Solutions, Inc.

Memphis, Tennessee, United States

CNS Healthcare

Memphis, Tennessee, United States

Bayou City Research Corporation

Houston, Texas, United States

Road Runner Research

San Antonio, Texas, United States

Ericksen Research & Development

Clinton, Utah, United States

Northwest Clinical Trials

Bellevue, Washington, United States